ARK Genomic Revolution ETF
ARKG
ARKG
283 hedge funds and large institutions have $610M invested in ARK Genomic Revolution ETF in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 65 increasing their positions, 102 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
283
Holders Change
-14
Holders Change %
-4.71%
% of All Funds
4.1%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
27
Increased
65
Reduced
102
Closed
36
Calls
$49.5M
Puts
$121M
Net Calls
-$71M
Net Calls Change
-$49.1M
Top Buyers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
$67M |
| 2 |
JPMorgan Chase & Co
New York
|
$32.5M |
| 3 |
Wells Fargo
San Francisco,
California
|
$37.5M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$8.84M |
| 5 |
Citigroup
New York
|
$26.1M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
$56.2M |
| 2 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
$21.4M |
| 3 |
Goldman Sachs
New York
|
$9.95M |
| 4 |
Two Sigma Advisers
New York
|
$3.66M |
| 5 |
Two Sigma Investments
New York
|
$6.24M |
